Literature DB >> 10439121

Amyloid and lipids in the pathology of Alzheimer disease.

A E Roher1, Y M Kuo, K M Kokjohn, M R Emmerling, S Gracon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10439121     DOI： 10.3109/13506129909007315

Source DB:  PubMed          Journal:  Amyloid        ISSN： 1350-6129            Impact factor:   7.141


× No keyword cloud information.
  15 in total

1.  Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease.

Authors:  I Masse; R Bordet; D Deplanque; A Al Khedr; F Richard; C Libersa; F Pasquier
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

Review 2.  The effects of cholesterol on learning and memory.

Authors:  Bernard G Schreurs
Journal:  Neurosci Biobehav Rev       Date:  2010-05-12       Impact factor: 8.989

3.  Silymarin ameliorates memory deficits and neuropathological changes in mouse model of high-fat-diet-induced experimental dementia.

Authors:  Amit Kumar; Amteshwar S Jaggi; Rupinder K Sodhi; Nirmal Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-05-28       Impact factor: 3.000

Review 4.  Dietary lipids in the aetiology of Alzheimer's disease: implications for therapy.

Authors:  Janelle L Cooper
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

5.  What is a genetic cause? The example of Alzheimer's Disease.

Authors:  Wim Dekkers; Marcel Olde Rikkert
Journal:  Med Health Care Philos       Date:  2006

Review 6.  Alzheimer's disease--a dysfunction in cholesterol and lipid metabolism.

Authors:  Walter J Lukiw; Miguel Pappolla; Ricardo Palacios Pelaez; Nicolas G Bazan
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

7.  Potential of ezetimibe in memory deficits associated with dementia of Alzheimer's type in mice.

Authors:  Yogita Dalla; Nirmal Singh; Amteshwar Singh Jaggi; Dhandeep Singh; Pooja Ghulati
Journal:  Indian J Pharmacol       Date:  2009-12       Impact factor: 1.200

8.  Heterogeneous Inhibition in Macroscopic Current Responses of Four Nicotinic Acetylcholine Receptor Subtypes by Cholesterol Enrichment.

Authors:  Carlos A Báez-Pagán; Natalie Del Hoyo-Rivera; Orestes Quesada; José David Otero-Cruz; José A Lasalde-Dominicci
Journal:  J Membr Biol       Date:  2016-04-26       Impact factor: 1.843

9.  Statin therapy for Alzheimer's disease: will it work?

Authors:  Suzana S Petanceska; Steven DeRosa; Vicki Olm; Nichole Diaz; Ali Sharma; Tara Thomas-Bryant; Karen Duff; Miguel Pappolla; Lorenzo M Refolo
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

10.  Generation of a recombinant Fab antibody reactive with the Alzheimer's disease-related Abeta peptide.

Authors:  A H Tammer; G Coia; R Cappai; S Fuller; C L Masters; P Hudson; J R Underwood
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.